Next Article in Journal
Wine, Beer, Alcohol and Polyphenols on Cardiovascular Disease and Cancer
Next Article in Special Issue
Effects of Egg White Protein Supplementation on Muscle Strength and Serum Free Amino Acid Concentrations
Previous Article in Journal
Selected Vitamins and Essential Elements in Meat from Semi-Domesticated Reindeer (Rangifer tarandus tarandus L.) in Mid- and Northern Norway: Geographical Variations and Effect of Animal Population Density
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 4
Issue 7
10.3390/nu4070740
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Exercise and Amino Acid Anabolic Cell Signaling and the Regulation of Skeletal Muscle Mass

by
Stefan M. Pasiakos
Military Nutrition Division, United States Army Research Institute of Environmental Medicine, 15 Kansas Street, Building 42, Natick, MA 01760, USA
Nutrients 2012, 4(7), 740-758; https://doi.org/10.3390/nu4070740
Submission received: 31 May 2012 / Revised: 29 June 2012 / Accepted: 2 July 2012 / Published: 10 July 2012
(This article belongs to the Special Issue Interaction of Amino Acids and Dietary Proteins and Exercise on Muscle Health)
Browse Figures
Versions Notes

Abstract

:
A series of complex intracellular networks influence the regulation of skeletal muscle protein turnover. In recent years, studies have examined how cellular regulators of muscle protein turnover modulate metabolic mechanisms contributing to the loss, gain, or conservation of skeletal muscle mass. Exercise and amino acids both stimulate anabolic signaling potentially through several intracellular pathways including the mammalian target of rapamycin complex 1 and the mitogen activated protein kinase cell signaling cascades. As novel molecular regulators of muscle integrity continue to be explored, a contemporary analysis of the literature is required to understand the metabolic mechanisms by which contractile forces and amino acids affect cellular process that contribute to long-term adaptations and preservation of muscle mass. This article reviews the literature related to how exercise and amino acid availability affect cellular regulators of skeletal muscle mass, especially highlighting recent investigations that have identified mechanisms by which contractile forces and amino acids modulate muscle health. Furthermore, this review will explore integrated exercise and nutrition strategies that promote the maintenance of muscle health by optimizing exercise, and amino acid-induced cell signaling in aging adults susceptible to muscle loss.

1. Introduction

Exercise and amino acids (AA) stimulate skeletal muscle protein turnover by modulating the activity of complex intracellular signaling networks including the mammalian target of rapamycin complex 1 (mTORC1) and the mitogen activated protein kinase (MAPK) signaling cascades [1]. Evidence from in vitro and in vivo laboratory animal studies demonstrates that mechanical loading initiates muscle protein turnover and anabolic intracellular signaling, thus the mode of exercise performed differentially influences acute and long-term muscle protein responses [2]. Cell membrane stretch-activated calcium channels, intracellular phospholipase D (PLD), and the lipid second messenger phosphatidic acid (PA), have been identified as possible mechanical sensors that may influence muscle intracellular responses to exercise, although the mechanisms by which these unique mechanosensors function in human skeletal muscle have not been determined [3,4].
It is also widely accepted that increasing plasma and muscle intracellular AA concentrations stimulate muscle protein synthesis (MPS) [5]. Increasing exogenous AA with exercise potentiates the MPS response initiated by mechanical loading by further enhancing mTORC1 activation through intracellular AA sensing mechanisms including the human vacuolar protein sorting-34 (hVps34) [6,7,8], mitogen activated protein kinase kinase kinase kinase-3 (MAP4K3) [9], the Rag subfamily of Ras small GTPases [10], and also by increasing AA transporter expression [11,12,13]. Although the independent effects of exogenous AA administration and the mechanical stress associated with exercise on intracellular signaling and muscle protein turnover are becoming clear, the cellular mechanisms by which exercise and amino acids combine to contribute to the loss, gain, or conservation of muscle mass remain poorly defined.
This article provides a concise contemporary review of independent and combined metabolic effects of exercise and AA on intracellular regulators of skeletal muscle mass. Studies identifying novel mechanisms by which contractile forces and AA elicit metabolic responses that may modulate muscle health will be highlighted. Further, this article will explore integrated exercise and nutrition strategies to promote the maintenance of muscle integrity by optimizing exercise and amino acid-mediated cell signaling in aging adults susceptible to muscle loss.

2. Exercise and Intracellular Regulation of Muscle Mass

Skeletal muscle is a highly adaptive tissue, sensitive to mechanical stress. Sustained mechanical loading can elicit muscle hypertrophy, whereas a chronic decrease in mechanical tension can contribute to muscle atrophy [14]. Adaptations in response to mechanical stress are in large part contingent on alterations in MPS, given that a single bout of resistance exercise can result in elevated MPS that persists 48-h into recovery [15]. Recent studies demonstrated that mTORC1 signaling and MPS responses to resistance exercise differs in magnitude and duration when the total volume and load placed on the muscle [16,17,18], length of time that muscle is under tension [19], and the velocity of contractile forces generated (e.g., eccentric and concentric) are manipulated [20]. Although acute anabolic responses to resistance exercise manipulations may vary, meaningful gains of muscle mass are generally observed with most long-term resistance exercise training programs [2]. However, contractile forces generated with steady-state exercise are typically much lower than those observed with resistance exercise so acute and long-term muscle protein responses to endurance-type exercise also likely differ. Nevertheless, studies have demonstrated that prolonged, steady-state exercise does stimulate anabolic intracellular signaling, MPS, and in particular the synthesis of mitochondrial muscle proteins during recovery, a metabolic response that some suggest is essential to promote repair and aerobic adaptations to endurance-type exercise [21,22,23,24]. Regardless of exercise mode, the principal conclusion from these studies is that the mechanical strain associated with the contractile forces generated by exercise is a central physiological driver of protein accretion [14,25].
Mechanotransduction is the term used to describe the conversion of mechanical stress into a biochemical signal that triggers anabolic intracellular signaling and MPS [26]. However the mechanisms by which these signals are transmitted are not well described. Baar and Esser [27] first demonstrated that gains in muscle mass were associated with mechanical loading-induced phosphorylation of the 70-kDa ribosomal protein S6 kinase 1 (p70S6K1), a signaling protein originally identified as a growth factor (i.e., mitogen) activated protein kinase involved with messenger ribonucleic acid (mRNA) translation. A subsequent report from Bodine et al. [28] showed that the activity of p70S6K1 and subsequent gains in muscle mass were mTORC1-dependent. Considering that exercise stimulates growth factor secretion, mainly the release of insulin-like growth factor 1 (IGF-1), it was originally hypothesized that autocrine release of IGF-1 in response to exercise transmitted a signal via a membrane bound receptor that activated mTORC1 and subsequently p70S6K1 through the insulin/IGF-1 phosphatidylinositol 3-kinase (PI3K) signaling pathway [29]. In theory, muscle hypertrophy would occur when exercise-induced growth factor signaling was stimulated repetitively with habitual exercise training.
The growth factor-mediated anabolic signaling and hypertrophy paradigm became the accepted model of mechanotransduction regulation of muscle mass. However, using an in vitro model, Hornberger et al. [26] demonstrated that p70S6K1 activation resulting from exercise occurred despite pharmacologic inhibition of IGF-1. For the first time these data suggest that IGF-1 stimulated PI3K signaling may not be necessary to elicit increased mTORC1 activity. Evidence from genetic animal model studies confirmed that mTORC1 and p70S6K1 activation and subsequent muscle hypertrophy are, at least in part, independent of IGF-1 stimulated PI3K signaling [30,31]. A recent report from Hamilton et al. [32] using intact, non-genetically modified animals further demonstrates the inability of resistance exercise to modulate IFG-1 signaling, as an acute bout of resistance-type exercise failed to activate the IFG-1 membrane bound receptor. Two other recent studies may provide the most compelling evidence to support the IGF-1/PI3K-independent hypothesis by assessing mTORC1 signaling, MPS, and long-term muscle hypertrophy adaptations to varying resistance exercise protocols designed to elicit vast differences in anabolic hormone concentrations [33,34]. In these studies, healthy young men performed two resistance exercise bouts on separate days. One bout consisted of an isolated elbow flexor exercise designed to maintain basal hormone concentrations (low hormone), and the second bout included the same arm exercise on the contralateral arm, immediately followed by heavy leg resistance exercise designed to elicit large increases in anabolic hormones (high hormone). Despite a 10-fold increase in IGF-1 and growth hormone levels in the high hormone state, no acute differences in p70S6K1 phosphorylation and MPS were observed between the low and high hormone resistance exercise protocols [34]. Furthermore, overall increases in muscle fiber cross sectional area and muscle strength following 15-weeks of training were not different between high and low hormone resistance exercise protocols [33]. Although the critical role of IGF-1 in the development of maturing tissue cannot be discounted, in the context of mTORC1 and subsequent hypertrophy, these data strongly suggest that mechanisms other than growth factor-induced anabolic intracellular signaling play a major role in mechanotransduction and long-term muscle adaptations to exercise.

Intracellular Signaling, Mechanosensing, and the Anabolic Response to Exercise

Intracellular regulation of mRNA translation and MPS responses to exercise are mediated by mTORC1 modulation of the phosphorylation states of two downstream target substrates, p70S6K1, and the translational repressor eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) (Figure 1) [1]. However, the MAPK cascade may also play a critical role in skeletal muscle adaptations to exercise, as the activity of this signaling pathway is positively associated with muscle growth, and sensitive to inflammatory, growth factor, and cellular stress responses to exercise [35,36,37,38]. Extracellular signal-regulated kinases 1 and 2 (ERK 1/2), p38 MAPK, c-Jun NH2-terminal kinases (JNK), and ERK 5 are the four primary components of the MAPK signaling cascade [35]. Drummond et al. [39] was the first to demonstrate in human skeletal muscle that maximal anabolic responses to resistance exercise are, in part, dependent on the co-activation of the MAPK and mTORC1 signaling cascades. Moore et al. [40] confirmed these findings in human muscle, as enhanced phosphorylation of ERK 1/2 and the 90-kDa ribosomal S6 kinase (p90RSK) were demonstrated with concomitant elevations in MPS and mTORC1 activation during recovery from high-volume, single-joint resistance exercise. Elevated p38, JNK, and ERK 1/2 phosphorylation were also recently demonstrated in human skeletal muscle during the first several hours of recovery from high-power, multi-joint resistance exercise [41]. The authors of this study hypothesized that MAPK signaling responses during the early stages of recovery from high-intensity resistance exercise may contribute to long-term muscle adaptations to resistance training. In support of this hypothesis, the relationship between MAPK and mTORC1 signaling was recently demonstrated using a less traditional non-physiological protocol to induce muscle growth, further suggesting that MAPK signaling is intricately involved in muscle hypertrophic responses to exercise [42]. Miyazaki et al. [42] used a 10-day synergist ablation mechanical overload model to induce hypertrophy in laboratory animals. Muscle hypertrophy, increased MPS, and PI3K-independent elevations in p70S6K1 phosphorylation (i.e., increased p70S6K1 phosphorylation occurred before elevations in PI3K signaling) were observed in as little as 1-day of mechanical stress, with concomitant increases in the phosphorylation of mitogen activated protein kinase kinase (MEK 1/2), ERK 1/2, and the tuberous sclerosis complex 2 (TSC2), a key substrate for MEK/ERK signaling. Considering the TSC2 complex is an upstream regulator of mTORC1 and MPS, these data support the hypothesis that mTORC1 anabolic signaling responses to exercise are co-regulated by the MAPK pathway.
Based on those findings, it appears that initial MAPK, mTORC1, and MPS responses to exercise are IGF-1/PI3K-independent. However, the precise mechanism by which mechanical stressors initiate muscle anabolism is still undetermined. Spangenburg and McBride [43] demonstrated that pharmacologic inhibition of stretch activated ion channels (SAC) in laboratory animals blocked resistance exercise-induced p70S6K1 phosphorylation [43]. Intracellular calcium flux is regulated in part by the SAC, and elevations in intracellular calcium may stimulate a calcium/calmodulin interaction with hVps34 (CaM complex/Vps34), which subsequently activates mTORC1 (3-h post-exercise) in the presence of contractile-induced elevations in intracellular AA levels [8]. Therefore, SAC-mediated increases in intracellular calcium levels may function as a critical mechanosensing mechanism contributing to the intracellular anabolic response to exercise. In fact, increasing intracellular calcium using a calcium ionophore in isolated muscle cells has been demonstrated to independently stimulate MPS [4]. Mechanically stretching these muscle cells with concomitant increases in intracellular calcium levels produced a more pronounced stimulation of MPS [4]. However, mechanical activation of mTORC1 signaling was also demonstrated despite when chelation induced a dramatic reduction in intracellular calcium concentrations [26]. Bodine et al. [28] also demonstrated that blockade of CaM using pharmacologic calceurin inhibitors, cyclosporin A and FK506, failed to inhibit muscle hypertrophy. However, the concept of calcium-mediated regulation of skeletal muscle mass remains contested [44]. Nevertheless, these findings suggest the existence of other potential mechanosensors, besides SAC-regulated calcium flux, which also act to trigger the anabolic signaling response to exercise.
Nutrients 04 00740 g001 1024
Figure 1. Simplified schematic of mechanotransduction-mediated anabolic signaling.
Figure 1. Simplified schematic of mechanotransduction-mediated anabolic signaling.
Nutrients 04 00740 g001
The phospholipid enzyme PLD and subsequent product PA may also play a role in mechanotransduced activation of mTORC1 signaling. In a series of in vitro and in vivo laboratory animal experiments, Hornberger et al. [3] demonstrated that: (1) elevations in PA concentrations activated mTORC1 signaling; (2) the PLD isozymes (PLD1 and PLD2) are localized at the z-line of the sarcomere, a central site for contractile force transmission; (3) mechanical stress via eccentric loading stimulated PLD activation, PA accumulation, and mTORC1 signaling; and (4) pharmacologic inhibition of PLD blocked mechanical stress-induced elevations in PA concentrations and mTORC1 signaling. In a subsequent study, O’Neil et al. [45] demonstrated that mechanical stress-induced PA accumulation was necessary to stimulate mTORC1 activity and consequent muscle hypertrophy using a similar scientific approach. Furthermore, anabolic signaling responses to elevations in PA concentrations were independent of IFG-1/PI3K signaling, as growth factor signaling was blocked pharmacologically. The mechanism by which this occurs appears to be through a direct activation of the mTOR kinase, as PA competitively binds with the FKBP12-rapamycin binding domain on mTOR [46]. These data indicate that mTORC1 activation in response to mechanical loading is PLD-dependent, which may, in part, contribute to exercise-induced muscle hypertrophy. Although these mechanisms will likely be explored in greater detail in future studies, it is important to note that PA-mediated anabolic intracellular signaling has not been thoroughly examined in human skeletal muscle. Furthermore, though studies suggest that PLD and subsequent PA serve a critical regulatory role in mTORC1 signaling following resistance exercise, it must be recognized that stimulation of mTORC1 in response to other mitogen stimuli is also PLD/PA-dependent [47].

3. Amino Acid Regulation of Muscle Protein Synthesis

Skeletal muscle protein turnover is also regulated by circulating AA concentrations [5]. Increasing plasma and muscle intracellular AA above fasting levels promotes a robust anabolic response that generally exceeds those elicited by exercise performed in the absence of nutrition [1]. The anabolic response is transient, with MPS reaching maximal stimulation within 2 h after consuming AA before rapidly returning to postabsorptive levels under resting conditions [48,49]. The stimulation of MPS in response to AA are dependent on the availability of essential amino acids (EAA), as non-essential amino acids are not required to stimulate MPS [50]. Although increasing levels of each EAA is required to maximize human MPS [5,51], the branched-chain amino acid (BCAA) leucine is particularly important, as several in vitro and in vivo animal studies have demonstrated that leucine independently stimulates MPS [52,53,54].
The quantity and quality of AA provided, and the conditions during which AA are administered, dictate the skeletal muscle anabolic response to AA. Reports indicate that MPS at rest and in recovery from resistance-type exercise reaches maximal stimulation after consuming 10 g of EAA with an amino acid profile consistent with a 20 g serving of high-quality protein [55,56]. Increasing the concentration of leucine within a maximal dose of EAA does not confer a greater anabolic stimulus at rest and following resistance-type exercise [57,58]. Under those conditions, intracellular AA transport appears saturated, as consuming a leucine-enriched maximal dose of EAA (3.5 g of leucine within 10 g of EAA) stimulates leucine transport to the muscle but does not enhance muscle intracellular leucine concentrations [57,59]. However, consuming a maximal dose of EAA that is enriched with leucine under conditions of increased metabolic demand such as during steady-state exercise may spare endogenous protein and enhance MPS in recovery [60]. Furthermore, consuming a sub-optimal dose of protein that is enriched with leucine following a bout of resistance exercise also appears to confer a similar anabolic stimulus when compared to a maximal dose of high-quality protein [13]. Leucine-enriched AA nutrition may also benefit older adults and contribute to the conservation of skeletal muscle mass by overcoming the anabolic resistance to consuming protein that is typically observed in aging skeletal muscle [61,62].
EAA and particularly leucine act as nutrient signals stimulating MPS by triggering critical steps involved with mRNA translation through the mTORC1 signaling network [63,64]. Transient elevations in plasma insulin concentrations secondary to AA administration [52,65], with concomitant changes in the expression and activity hVps34 [6,7], MAP4K3 [9], and subsequent long-term adaptations of the Rag GTPases [10,66], play a central role in the regulation of AA-induced mTORC1 signaling and MPS. Recent studies also suggest that the function of specific AA transporters contribute to the regulation of MPS in response to various stressors by modulating AA flux, ultimately enhancing muscle intracellular AA availability [11,12,67].

Amino Acid Sensing, Transport, and Anabolic Intracellular Signaling

Leucine is an established insulin secretagogue [68], and acute administration of excess leucine stimulates an increase in plasma insulin, resulting in enhanced mTORC1 signaling and MPS (Figure 2) [69,70]. The stimulation of MPS attributed to insulin occurs upstream of mTORC1 through PI3K and subsequent phosphorylation of protein kinase B (PKB/Akt). Under that regulatory control, Akt indirectly stimulates mTORC1 by phosphorylating TSC2, thereby activating the GTPase protein, Ras homolog enriched with brain (RHEB) [71]. Pharmacologic inhibition of insulin secretion fails to block leucine mediated mTORC1 signaling in laboratory animals [52,69]. These data suggest that AA stimulate anabolic signaling through both an insulin-dependent and independent mechanism. However, intracellular signaling and MPS responses to insulin inhibition were lower in comparison to animals with normal insulin function. As such, the degree to which leucine stimulates mTORC1 signaling may rely to an extent upon concomitant increases in insulin concentrations. More specifically, using an animal model, Crozier et al. [72] demonstrated that early stimulation of MPS in response to leucine administration was not reliant on insulin, but maximal stimulation of mTORC1 was dependent on elevations in circulating insulin concentrations. Pharmacologic-induced insulinemia in humans also fails to potentiate MPS responses to AA provision [73]. However, similar to the study by Crozier et al. [72], the stimulation of the mTORC1 was insulin-dependent, which suggest that a dissociative relationship between anabolic intracellular signaling and MPS responses to AA and insulin manipulations may exit [73].
In vitro studies suggest that hVps34 and MAP4K3 also contribute to insulin-independent, AA-induced regulation of mTORC1 signaling [6,7,9]. The hVps34 protein is a novel class 3 PIK that lies upstream of mTORC1. The activity of this lipid kinase is regulated in part by AA concentrations: hVps34 activity is attenuated with nutrient depletion, whereas increasing AA concentrations activates hVps34, phosphorylates p70SK1, and inhibits 4E-BP1 [6]. MacKenzie et al. [8] demonstrated that not only do contractile-induced elevations in leucine stimulate hVps34 activity, but sustained (3-h) provision of leucine to isolated muscle cells activates hVps34, which the authors suggest may prolong mTORC1 stimulation and contribute to long-term muscle hypertrophy. Gulati et al. [74] also demonstrated that elevations in AA concentrations modulate cellular calcium flux, causing the aforementioned CaM complex/Vps34 interaction and concomitant activation of mTORC1. In addition, MAP4K3, which was recently identified in Drosophila, is required for AA-induced stimulation of p70SK1 and 4E-BP1 through mTORC1 [9]. However, the mechanism by which MAP4K3 responds to fluctuations in AA concentrations to modulate mTORC1 activity is not well described. More importantly, not all studies support the interaction between these unique nutrient sensors, AA, and mTORC1 activity [75], and no studies have clearly identified the role of hVps34 and MAP4K3 in anabolic intracellular signaling and MPS in human skeletal muscle [76].
Nutrients 04 00740 g002 1024
Figure 2. Simplified schematic of amino acid-mediated anabolic signaling.
Figure 2. Simplified schematic of amino acid-mediated anabolic signaling.
Nutrients 04 00740 g002
The functions of the Rag subfamily of Ras small GTPase proteins are associated with AA-mediated mTORC1 activation. Two independent groups of the four Rag GTPases that mammalian cells express (RagA, RagB, RagC, and RagD) modulate anabolic cell signaling through mTORC1 by functioning as heterodimers and binding with the mTORC1 associated protein Raptor. Raptor acts as an adaptor protein, recruiting substrates for mTORC1 phosphorylation, primarily p70SK1 and 4E-BP1 [10,66,77]. However, Rag interaction with mTORC1 does not directly activate the mTOR kinase; rather Rag proteins modulate cellular translocation of mTORC1 to the lysosome that facilitates an mTOR and RHEB interaction, which in the presence of elevated AA concentrations, results in RHEB-induced activation of mTORC1. Leucyl-tRNA synthetase (LRS) may be a novel AA sensing mechanism that functions in concert with Rag to activate mTORC1, as Han et al. [78] recently demonstrated that LRS binds directly with Rag, subsequently mediating GTPase activation and mTORC1 signaling in an AA-dependent manner. As such, Rag-mediated mTORC1 translocation and subsequent activation in response to AA sufficiency may prove to be the primary mechanism responsible for increased MPS following AA administration.
Muscle intracellular AA transport proteins function as critical links connecting anabolic intracellular signaling to manipulations in AA concentrations by shuttling AA across cell membranes [79,80]. System L (L-type amino acid transporter 1(LAT1)/solute-linked carrier (SLC) 7A5 and CD98/SLC3A2 heterodimeric complex) and system A (sodium-coupled neutral AA transporters (SNAT2/SLC38A2)) transporters are involved in the regulation of intracellular AA concentrations by transporting large neutral AA (e.g., branched-chain amino acids) into muscle cells [81]. The expression and function of LAT1/CD98 and SNAT2 are positively associated with muscle growth, mTORC1 activation, and MPS [82,83]. In response to elevations in extracellular AA concentrations, SNAT2 increases glutamine influx, stimulating the LAT1/CD98-regulated bitransport system that exports glutamine out of the cell in exchange for leucine.
Interactions between dietary AA manipulations and transporter-mediated anabolic intracellular signaling in human skeletal muscle have recently been investigated in a series of studies by Drummond et al. [11,12,67]. Intracellular leucine kinetics, MPS, mTORC1 signaling, and AA transporter expression were determined in healthy young adults before and after consuming a 10 g EAA supplement [12]. EAA ingestion resulted in increased leucine delivery to the muscle, intramuscular leucine concentrations, MPS, and mTORC1 activation. The anabolic response to EAA administration occurred with concomitant increases in LAT1 and SNAT2 expression suggesting a unique regulatory mechanism that may contribute AA-induced stimulation of MPS by enhancing the availability of AA. Drummond et al. [67] also demonstrated that 7 days of bed in older adults attenuates MPS, mTORC1 signaling, and LAT1 and SNAT2 protein content responses to EAA ingestion. These data demonstrate that relatively short periods of physical inactivity may contribute to age-related muscle loss by further desensitizing aging skeletal muscle to the potent anabolic stimulus of AA. Whether other conditions associated with muscle loss such as those experienced with weight loss in response to extended periods of energy deficiency result in similar patterns of AA transporter expression, mTORC1 signaling, and MPS responses to dietary AA manipulations has not been determined.

4. Integrated Regulation of Muscle Mass by Exercise and Amino Acids

It is evident that exercise and AA stimulate mTORC1 independent of IGF-1/PI3K signaling through unique mechanotransduction and AA sensing mechanisms. However, mTORC1 signaling and subsequent MPS stimulation initiated by mechanical stress is more efficient in the presence of elevated AA concentrations [84]. As such, combining the metabolic effects of exercise with exogenous AA administration results in more a pronounced and sustained anabolic response than either stimulus can generally elicit alone, indicating that exercise and AA-mediated cell signaling are highly integrated. For example, mechanical loading through SAC-mediated calcium flux and enhanced intracellular AA concentrations both have the ability to activate the nutrient sensitive hVps34 kinase, stimulating RHEB-induced mTORC1 activation [6,7,8]. Furthermore, mechanical loading also modulates muscle intracellular membrane permeability to extracellular AA, which may enhance AA uptake [85], and stimulate mTORC1 signaling via hVps34, MAP4K3, and Rag GTPases-dependent mechanisms. Considering that exercise may independently modulate intracellular AA concentrations, the principal substrate for MPS, it is rather predictable that investigations consistently demonstrate enhanced mTORC1, MPS, and hypertrophic responses to mechanical stimuli when exercise is combined with AA supplementation (Figure 3) [1]. As such, exercise and nutrition strategies that effectively integrate mechanotransduction and AA-mediated intracellular signaling may conserve muscle health in populations predisposed to muscle loss.
Nutrients 04 00740 g003 1024
Figure 3. Simplified illustration of the combined effects of mechanotransduction and amino acid-mediated anabolic signaling on skeletal muscle integrity.
Figure 3. Simplified illustration of the combined effects of mechanotransduction and amino acid-mediated anabolic signaling on skeletal muscle integrity.
Nutrients 04 00740 g003

Exercise, Amino Acids, and the Conservation of Muscle Mass

Reduced skeletal muscle mass coupled with an increase in body fat is among the most debilitating and consistent changes associated with aging. Age-related muscle loss is referred to as sarcopenia, which is clinically defined as presentation with muscle mass at least two standard deviations below the average muscle mass of a younger adult 35 years of age [86]. The rate of skeletal muscle loss can be much as 1% per year after 30 years of age, which continues until the end of life [87]. Although the etiology of sarcopenia is multifaceted, the most evident metabolic explanation for the decline in muscle mass is an imbalance between rates of MPS and proteolysis [88]. The reduction in muscle mass with aging can degrade strength, metabolic rate, aerobic capacity, and muscular function, thereby reducing quality of life [89], and predisposing elderly individuals to illness, fractures, and other chronic metabolic conditions such as obesity and type 2 diabetes [90], which ultimately increase mortality [91].
Multiple reports have demonstrated that aging skeletal muscle is desensitized to exogenous AA administration [61,92,93]. In fact, anabolic resistance to AA is considered a major contributor to age-related muscle loss [61]. However, this phenomenon may be overcome by manipulating the leucine content of an AA supplement or of a protein containing meal [61,62]. In a recent review, Breen and Phillips [94] hypothesized the existence of a leucine threshold, which must be surpassed to maximize MPS and mTORC1 signaling. They suggest that this threshold differs between young and aging muscle, where 1 g of leucine combined with resistance exercise in young adults is sufficient to stimulate MPS above resting conditions [56], but 2 g of leucine may be required to stimulate MPS above resting conditions in older adults after resistance exercise [95]. Interestingly, and in contrast to young adults [56], MPS in older adults reaches maximal stimulation after resistance exercise when approximately 4 g of leucine (40 g whey protein) is consumed. These findings are not only consistent with earlier reports in older adults [61,62] but also similar to recent data from our laboratory that suggest that leucine requirements may not only be dependent on age but also perhaps by the metabolic demand for energy and AA [60].
Evidence also demonstrates that MPS and mTORC1 signaling responses to resistance exercise are blunted in older compared to younger adults [96,97,98]. A recent report suggests that AA transporter expression may be a contributing factor to age-related anabolic resistance to mechanical loading [11]. Drummond et al. [11] demonstrated increased LAT1 expression with concomitant elevations in mTORC1 signaling in young adults, yet no changes in transporter expression and anabolic signaling in older adults following a bout of resistance exercise. However, manipulating the volume of mechanical overload may prove to be an effective compensatory strategy against anabolic resistance to exercise, which may contribute to the conservation of muscle mass [96,97]. Fry et al. [99] demonstrated that combining low-intensity, high-volume resistance exercise with blood flow restriction (i.e., leg blood flow was restricted using a lower extremity pressure cuff; Kaatsu-Master Mini, Tokyo, Japan), stimulated marked increases in MPS and mTORC1 signaling in older adults; although the practical applications (e.g., access to pressure cuffs and potential for discomfort) of blood flow restricted exercise may be limiting. Other studies recommend that older adults perform low-intensity, high-volume resistance exercise to muscle failure to impose a cumulative mechanical load that is greater than those typically observed with high-intensity, low-volume resistance exercise [18]. Therefore, low-intensity, high-volume exercise to muscle failure or perhaps when safely combined with blood flow restriction may be an effective anabolic stimulus and form of exercise therapy for older adults to perform in comparison to conventional resistance exercise training [97]. Furthermore, the most effective strategy against age-related muscle loss is arguably the combination of exercise with AA (or high-quality protein) supplementation, as there is no shortage of reports that demonstrate acute mTORC1 and MPS responses to exercise and AA and protein consumption are more pronounced in older adults when these anabolic stimuli are combined [11,12,76,95,100]. Whether acute anabolic intracellular signaling and MPS responses result in long-term conservation of muscle mass following structured, low-intensity, high-volume exercise training with optimized nutritional support has not been determined.

5. Conclusions

The distinct metabolic effects by which exercise and AA modulate anabolic intracellular signaling, MPS, and contribute to the regulation of muscle mass have been studied extensively in recent years. Intracellular calcium concentrations mediated by SAC and PA accumulation triggered by PLD have been identified as distinct mechanosensors stimulating mTORC1 activity in response to mechanical stress. Nutrient sensing mechanisms including hVps34, MAP4K3, and the Rag GTPases appear to modulate mTORC1 localization and activation in response to elevations in AA concentrations. The expression and activity of multiple intracellular AA transport proteins may also serve a critical role in regulating anabolic responses to AA supplementation by enhancing the availability of leucine. Interestingly, exercise also shares the ability to alter intracellular AA concentrations and subsequent mTORC1 signaling through similar nutrient sensitive mechanisms. Certainly, further study is necessary to confirm the function of these novel mechanotransduction and AA-sensing mechanisms demonstrated in in vitro and in vivo animal studies on human muscle protein metabolism in response to a variety of physiological stressors. Regardless of the mechanism, it is clear that exercise and exogenous AA supplementation are potent anabolic stimuli that can be used successfully as integrated therapies to promote muscle health in populations susceptible to muscle loss.

Acknowledgments

The author acknowledges Andrew J. Young for his critical and constructive review in support of the development of this manuscript. The author also sincerely thanks Charles Wulff and Philip Niro for their assistance with the design and layout of the manuscript figures. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Army or the Department of Defense. Any citations of commercial organizations and trade names in this report do not constitute an official Department of the Army endorsement of approval of the products or services of these organizations.

Conflict of Interest

The authors declare no conflict of interest.

References

  1. Drummond, M.J.; Dreyer, H.C.; Fry, C.S.; Glynn, E.L.; Rasmussen, B.B. Nutritional and contractile regulation of human skeletal muscle protein synthesis and mTORC1 signaling. J. Appl. Physiol. 2009, 106, 1374–1384. [Google Scholar] [CrossRef]
  2. Burd, N.A.; Mitchell, C.J.; Churchward-Venne, T.A.; Phillips, S.M. Bigger weights may not beget bigger muscles: Evidence from acute muscle protein synthetic responses after resistance exercise. Appl. Physiol. Nutr. Metab. 2012, 37, 551–554. [Google Scholar] [CrossRef]
  3. Hornberger, T.A.; Chu, W.K.; Mak, Y.W.; Hsiung, J.W.; Huang, S.A.; Chien, S. The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle. Proc. Natl. Acad. Sci. USA 2006, 103, 4741–4746. [Google Scholar]
  4. Kameyama, T.; Etlinger, J.D. Calcium-dependent regulation of protein synthesis and degradation in muscle. Nature 1979, 279, 344–346. [Google Scholar] [CrossRef]
  5. Wolfe, R.R.; Miller, S.L. Amino acid availability controls muscle protein metabolism. Diabetes Nutr. Metab. 1999, 12, 322–328. [Google Scholar]
  6. Byfield, M.P.; Murray, J.T.; Backer, J.M. hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase. J. Biol. Chem. 2005, 280, 33076–33082. [Google Scholar]
  7. Nobukuni, T.; Joaquin, M.; Roccio, M.; Dann, S.G.; Kim, S.Y.; Gulati, P.; Byfield, M.P.; Backer, J.M.; Natt, F.; Bos, J.L.; et al. Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc. Natl. Acad. Sci. USA 2005, 102, 14238–14243. [Google Scholar]
  8. MacKenzie, M.G.; Hamilton, D.L.; Murray, J.T.; Taylor, P.M.; Baar, K. mVps34 is activated following high-resistance contractions. J. Physiol. 2009, 587, 253–260. [Google Scholar] [CrossRef]
  9. Findlay, G.M.; Yan, L.; Procter, J.; Mieulet, V.; Lamb, R.F. A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling. Biochem. J. 2007, 403, 13–20. [Google Scholar] [CrossRef]
  10. Kim, E.; Goraksha-Hicks, P.; Li, L.; Neufeld, T.P.; Guan, K.L. Regulation of TORC1 by Rag GTPases in nutrient response. Nat. Cell Biol. 2008, 10, 935–945. [Google Scholar] [CrossRef]
  11. Drummond, M.J.; Fry, C.S.; Glynn, E.L.; Timmerman, K.L.; Dickinson, J.M.; Walker, D.K.; Gundermann, D.M.; Volpi, E.; Rasmussen, B.B. Skeletal muscle amino acid transporter expression is increased in young and older adults following resistance exercise. J. Appl. Physiol. 2011, 111, 135–142. [Google Scholar]
  12. Drummond, M.J.; Glynn, E.L.; Fry, C.S.; Timmerman, K.L.; Volpi, E.; Rasmussen, B.B. An increase in essential amino acid availability upregulates amino acid transporter expression in human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2010, 298, E1011–E1018. [Google Scholar] [CrossRef]
  13. Churchward-Venne, T.A.; Burd, N.A.; Mitchell, C.J.; West, D.W.; Philp, A.; Marcotte, G.R.; Baker, S.K.; Baar, K.; Phillips, S.M. Supplementation of a suboptimal protein dose with leucine or essential amino acids: Effects on myofibrillar protein synthesis at rest and following resistance exercise in men. J. Physiol. 2012, 590, 2751–2765. [Google Scholar] [CrossRef]
  14. Goldberg, A.L.; Etlinger, J.D.; Goldspink, D.F.; Jablecki, C. Mechanism of work-induced hypertrophy of skeletal muscle. Med. Sci. Sports 1975, 7, 185–198. [Google Scholar]
  15. Phillips, S.M.; Tipton, K.D.; Aarsland, A.; Wolf, S.E.; Wolfe, R.R. Mixed muscle protein synthesis and breakdown after resistance exercise in humans. Am. J. Physiol. 1997, 273, E99–E107. [Google Scholar]
  16. Mitchell, C.J.; Churchward-Venne, T.A.; West, D.D.; Burd, N.A.; Breen, L.; Baker, S.K.; Phillips, S.M. Resistance exercise load does not determine training-mediated hypertrophic gains in young men. J. Appl. Physiol. 2012. [Google Scholar] [CrossRef]
  17. Burd, N.A.; Holwerda, A.M.; Selby, K.C.; West, D.W.; Staples, A.W.; Cain, N.E.; Cashaback, J.G.; Potvin, J.R.; Baker, S.K.; Phillips, S.M. Resistance exercise volume affects myofibrillar protein synthesis and anabolic signalling molecule phosphorylation in young men. J. Physiol. 2010, 588, 3119–3130. [Google Scholar]
  18. Burd, N.A.; West, D.W.; Staples, A.W.; Atherton, P.J.; Baker, J.M.; Moore, D.R.; Holwerda, A.M.; Parise, G.; Rennie, M.J.; Baker, S.K.; et al. Low-load high volume resistance exercise stimulates muscle protein synthesis more than high-load low volume resistance exercise in young men. PLoS One 2010, 5, e12033. [Google Scholar]
  19. Burd, N.A.; Andrews, R.J.; West, D.W.; Little, J.P.; Cochran, A.J.; Hector, A.J.; Cashaback, J.G.; Gibala, M.J.; Potvin, J.R.; Baker, S.K.; et al. Muscle time under tension during resistance exercise stimulates differential muscle protein sub-fractional synthetic responses in men. J. Physiol. 2012, 590, 351–362. [Google Scholar]
  20. Shepstone, T.N.; Tang, J.E.; Dallaire, S.; Schuenke, M.D.; Staron, R.S.; Phillips, S.M. Short-term high- vs. low-velocity isokinetic lengthening training results in greater hypertrophy of the elbow flexors in young men. J. Appl. Physiol. 2005, 98, 1768–1776. [Google Scholar] [CrossRef]
  21. Carraro, F.; Hartl, W.H.; Stuart, C.A.; Layman, D.K.; Jahoor, F.; Wolfe, R.R. Whole body and plasma protein synthesis in exercise and recovery in human subjects. Am. J. Physiol. 1990, 258, E821–E831. [Google Scholar]
  22. Harber, M.P.; Crane, J.D.; Dickinson, J.M.; Jemiolo, B.; Raue, U.; Trappe, T.A.; Trappe, S.W. Protein synthesis and the expression of growth-related genes are altered by running in human vastus lateralis and soleus muscles. Am. J. Physiol. Regul. Integr.Comp. Physiol. 2009, 296, R708–R714. [Google Scholar]
  23. Harber, M.P.; Konopka, A.R.; Jemiolo, B.; Trappe, S.W.; Trappe, T.A.; Reidy, P.T. Muscle protein synthesis and gene expression during recovery from aerobic exercise in the fasted and fed states. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 299, R1254–R1262. [Google Scholar] [CrossRef]
  24. Sheffield-Moore, M.; Yeckel, C.W.; Volpi, E.; Wolf, S.E.; Morio, B.; Chinkes, D.L.; Paddon-Jones, D.; Wolfe, R.R. Postexercise protein metabolism in older and younger men following moderate-intensity aerobic exercise. Am. J. Physiol. Endocrinol. Metab. 2004, 287, E513–E522. [Google Scholar] [CrossRef]
  25. Goldberg, A.L. Protein synthesis during work-induced growth of skeletal muscle. J. Cell Biol. 1968, 36, 653–658. [Google Scholar] [CrossRef]
  26. Hornberger, T.A.; Stuppard, R.; Conley, K.E.; Fedele, M.J.; Fiorotto, M.L.; Chin, E.R.; Esser, K.A. Mechanical stimuli regulate rapamycin-sensitive signalling by a phosphoinositide 3-kinase-, protein kinase B- and growth factor-independent mechanism. Biochem. J. 2004, 380, 795–804. [Google Scholar] [CrossRef]
  27. Baar, K.; Esser, K. Phosphorylation of p70S6k correlates with increased skeletal muscle mass following resistance exercise. Am. J. Physiol. 1999, 276, C120–C127. [Google Scholar]
  28. Bodine, S.C.; Stitt, T.N.; Gonzalez, M.; Kline, W.O.; Stover, G.L.; Bauerlein, R.; Zlotchenko, E.; Scrimgeour, A.; Lawrence, J.C.; Glass, D.J.; et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 2001, 3, 1014–1019. [Google Scholar] [CrossRef]
  29. Goldspink, G. Mechanical signals, IGF-I gene splicing, and muscle adaptation. Physiology (Bethesda) 2005, 20, 232–238. [Google Scholar] [CrossRef]
  30. Spangenburg, E.E.; Le Roith, D.; Ward, C.W.; Bodine, S.C. A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy. J. Physiol. 2008, 586, 283–291. [Google Scholar]
  31. Goodman, C.A.; Miu, M.H.; Frey, J.W.; Mabrey, D.M.; Lincoln, H.C.; Ge, Y.; Chen, J.; Hornberger, T.A. A phosphatidylinositol 3-kinase/protein kinase B-independent activation of mammalian target of rapamycin signaling is sufficient to induce skeletal muscle hypertrophy. Mol. Biol. Cell 2010, 21, 3258–3268. [Google Scholar] [CrossRef]
  32. Hamilton, D.L.; Philp, A.; MacKenzie, M.G.; Baar, K. A limited role for PI(3,4,5)P3 regulation in controlling skeletal muscle mass in response to resistance exercise. PLoS One 2010, 5, e11624. [Google Scholar]
  33. West, D.W.; Burd, N.A.; Tang, J.E.; Moore, D.R.; Staples, A.W.; Holwerda, A.M.; Baker, S.K.; Phillips, S.M. Elevations in ostensibly anabolic hormones with resistance exercise enhance neither training-induced muscle hypertrophy nor strength of the elbow flexors. J. Appl. Physiol. 2010, 108, 60–67. [Google Scholar] [CrossRef]
  34. West, D.W.D.; Kujbida, G.W.; Moore, D.R.; Atherton, P.; Burd, N.A.; Padzik, J.P.; de Lisio, M.; Tang, J.E.; Parise, G.; Rennie, M.J.; et al. Resistance exercise-induced increases in putative anabolic hormones do not enhance muscle protein synthesis or intracellular signalling in young men. J. Physiol. 2009, 587, 5239–5247. [Google Scholar]
  35. Kramer, H.F.; Goodyear, L.J. Exercise, MAPK, and NF-kappab signaling in skeletal muscle. J. Appl. Physiol. 2007, 103, 388–395. [Google Scholar] [CrossRef]
  36. Coffey, V.G.; Zhong, Z.; Shield, A.; Canny, B.J.; Chibalin, A.V.; Zierath, J.R.; Hawley, J.A. Early signaling responses to divergent exercise stimuli in skeletal muscle from well-trained humans. FASEB J. 2006, 20, 190–192. [Google Scholar]
  37. Widegren, U.; Ryder, J.W.; Zierath, J.R. Mitogen-activated protein kinase signal transduction in skeletal muscle: Effects of exercise and muscle contraction. Acta Physiol. Scand. 2001, 172, 227–238. [Google Scholar] [CrossRef]
  38. Widegren, U.; Wretman, C.; Lionikas, A.; Hedin, G.; Henriksson, J. Influence of exercise intensity on ERK/MAP kinase signalling in human skeletal muscle. Pflugers Arch. 2000, 441, 317–322. [Google Scholar] [CrossRef]
  39. Drummond, M.J.; Fry, C.S.; Glynn, E.L.; Dreyer, H.C.; Dhanani, S.; Timmerman, K.L.; Volpi, E.; Rasmussen, B.B. Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis. J. Physiol. 2009, 587, 1535–1546. [Google Scholar] [CrossRef]
  40. Moore, D.R.; Atherton, P.J.; Rennie, M.J.; Tarnopolsky, M.A.; Phillips, S.M. Resistance exercise enhances mTOR and MAPK signalling in human muscle over that seen at rest after bolus protein ingestion. Acta Physiol. (Oxf.) 2011, 201, 365–372. [Google Scholar] [CrossRef]
  41. Galpin, A.J.; Fry, A.C.; Chiu, L.Z.; Thomason, D.B.; Schilling, B.K. High-power resistance exercise induces MAPK phosphorylation in weightlifting trained men. Appl. Physiol. Nutr. Metab. 2012, 37, 80–87. [Google Scholar] [CrossRef]
  42. Miyazaki, M.; McCarthy, J.J.; Fedele, M.J.; Esser, K.A. Early activation of mTORC1 signalling in response to mechanical overload is independent of phosphoinositide 3-kinase/Akt signalling. J. Physiol. 2011, 589, 1831–1846. [Google Scholar] [CrossRef]
  43. Spangenburg, E.E.; McBride, T.A. Inhibition of stretch-activated channels during eccentric muscle contraction attenuates p70S6K activation. J. Appl. Physiol. 2006, 100, 129–135. [Google Scholar] [CrossRef]
  44. Dunn, S.E.; Simard, A.R.; Prud’homme, R.A.; Michel, R.N. Calcineurin and skeletal muscle growth. Nat. Cell Biol. 2002, 4, E46, author reply E46-E47.. [Google Scholar]
  45. O’Neil, T.K.; Duffy, L.R.; Frey, J.W.; Hornberger, T.A. The role of phosphoinositide 3-kinase and phosphatidic acid in the regulation of mammalian target of rapamycin following eccentric contractions. J. Physiol. 2009, 587, 3691–3701. [Google Scholar] [CrossRef]
  46. Veverka, V.; Crabbe, T.; Bird, I.; Lennie, G.; Muskett, F.W.; Taylor, R.J.; Carr, M.D. Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: Compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR. Oncogene 2008, 27, 585–595. [Google Scholar] [CrossRef]
  47. Sun, Y.; Fang, Y.; Yoon, M.S.; Zhang, C.; Roccio, M.; Zwartkruis, F.J.; Armstrong, M.; Brown, H.A.; Chen, J. Phospholipase D1 is an effector of Rheb in the mTOR pathway. Proc. Natl. Acad. Sci. USA 2008, 105, 8286–8291. [Google Scholar]
  48. Bohe, J.; Low, J.F.; Wolfe, R.R.; Rennie, M.J. Latency and duration of stimulation of human muscle protein synthesis during continuous infusion of amino acids. J. Physiol. 2001, 532, 575–579. [Google Scholar] [CrossRef]
  49. Atherton, P.J.; Etheridge, T.; Watt, P.W.; Wilkinson, D.; Selby, A.; Rankin, D.; Smith, K.; Rennie, M.J. Muscle full effect after oral protein: Time-dependent concordance and discordance between human muscle protein synthesis and mTORC1 signaling. Am. J. Clin. Nutr. 2010, 92, 1080–1088. [Google Scholar] [CrossRef]
  50. Tipton, K.D.; Gurkin, B.E.; Matin, S.; Wolfe, R.R. Nonessential amino acids are not necessary to stimulate net muscle protein synthesis in healthy volunteers. J. Nutr. Biochem. 1999, 10, 89–95. [Google Scholar] [CrossRef]
  51. Wolfe, R.R. Regulation of muscle protein by amino acids. J. Nutr. 2002, 132, 3219–3224. [Google Scholar]
  52. Anthony, J.C.; Anthony, T.G.; Kimball, S.R.; Vary, T.C.; Jefferson, L.S. Orally administered leucine stimulates protein synthesis in skeletal muscle of postabsorptive rats in association with increased eIF4F formation. J. Nutr. 2000, 130, 139–145. [Google Scholar]
  53. Anthony, J.C.; Yoshizawa, F.; Anthony, T.G.; Vary, T.C.; Jefferson, L.S.; Kimball, S.R. Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J. Nutr. 2000, 130, 2413–2419. [Google Scholar]
  54. Buse, M.G.; Reid, S.S. Leucine. A possible regulator of protein turnover in muscle. J. Clin. Invest. 1975, 56, 1250–1261. [Google Scholar] [CrossRef]
  55. Cuthbertson, D.; Smith, K.; Babraj, J.; Leese, G.; Waddell, T.; Atherton, P.; Wackerhage, H.; Taylor, P.M.; Rennie, M.J. Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J. 2005, 19, 422–424. [Google Scholar]
  56. Moore, D.R.; Robinson, M.J.; Fry, J.L.; Tang, J.E.; Glover, E.I.; Wilkinson, S.B.; Prior, T.; Tarnopolsky, M.A.; Phillips, S.M. Ingested protein dose response of muscle and albumin protein synthesis after resistance exercise in young men. Am. J. Clin. Nutr. 2009, 89, 161–168. [Google Scholar]
  57. Glynn, E.L.; Fry, C.S.; Drummond, M.J.; Timmerman, K.L.; Dhanani, S.; Volpi, E.; Rasmussen, B.B. Excess leucine intake enhances muscle anabolic signaling but not net protein anabolism in young men and women. J. Nutr. 2010, 140, 1970–1976. [Google Scholar] [CrossRef]
  58. Koopman, R.; Verdijk, L.B.; Beelen, M.; Gorselink, M.; Kruseman, A.N.; Wagenmakers, A.J.; Kuipers, H.; van Loon, L.J. Co-ingestion of leucine with protein does not further augment post-exercise muscle protein synthesis rates in elderly men. Br. J. Nutr. 2007, 99, 1–10. [Google Scholar]
  59. Hundal, H.S.; Taylor, P.M. Amino acid transceptors: Gate keepers of nutrient exchange and regulators of nutrient signaling. Am. J. Physiol. Endocrinol. Metab. 2009, 296, E603–E613. [Google Scholar] [CrossRef]
  60. Pasiakos, S.M.; McClung, H.L.; McClung, J.P.; Margolis, L.M.; Andersen, N.E.; Cloutier, G.J.; Pikosky, M.A.; Rood, J.C.; Fielding, R.A.; Young, A.J. Leucine-enriched essential amino acid supplementation during moderate steady state exercise enhances postexercise muscle protein synthesis. Am. J. Clin. Nutr. 2011, 94, 809–818. [Google Scholar] [CrossRef]
  61. Katsanos, C.S.; Kobayashi, H.; Sheffield-Moore, M.; Aarsland, A.; Wolfe, R.R. A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am. J. Physiol. Endocrinol. Metab. 2006, 291, E381–E387. [Google Scholar] [CrossRef]
  62. Rieu, I.; Balage, M.; Sornet, C.; Giraudet, C.; Pujos, E.; Grizard, J.; Mosoni, L.; Dardevet, D. Leucine supplementation improves muscle protein synthesis in elderly men independently of hyperaminoacidaemia. J. Physiol. 2006, 575, 305–315. [Google Scholar] [CrossRef]
  63. Proud, C.G. Amino acids and mTOR signalling in anabolic function. Biochem. Soc. Trans. 2007, 35, 1187–1190. [Google Scholar] [CrossRef]
  64. Stipanuk, M.H. Leucine and protein synthesis: mTOR and beyond. Nutr. Rev. 2007, 65, 122–129. [Google Scholar] [CrossRef]
  65. Balage, M.; Sinaud, S.; Prod’homme, M.; Dardevet, D.; Vary, T.C.; Kimball, S.R.; Jefferson, L.S.; Grizard, J. Amino acids and insulin are both required to regulate assembly of the eIF4E. eIF4G complex in rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2001, 281, E565–E574. [Google Scholar]
  66. Sancak, Y.; Peterson, T.R.; Shaul, Y.D.; Lindquist, R.A.; Thoreen, C.C.; Bar-Peled, L.; Sabatini, D.M. The rag gtpases bind raptor and mediate amino acid signaling to mTORC1. Science 2008, 320, 1496–1501. [Google Scholar]
  67. Drummond, M.J.; Dickinson, J.M.; Fry, C.S.; Walker, D.K.; Gundermann, D.M.; Reidy, P.T.; Timmerman, K.L.; Markofski, M.M.; Paddon-Jones, D.; Rasmussen, B.B.; et al. Bed rest impairs skeletal muscle amino acid transporter expression, mTORC1 signaling, and protein synthesis in response to essential amino acids in older adults. Am. J. Physiol. Endocrinol. Metab. 2012, 302, E1113–E1122. [Google Scholar] [CrossRef]
  68. Floyd, J.C., Jr.; Fajans, S.S.; Pek, S.; Thiffault, C.A.; Knopf, R.F.; Conn, J.W. Synergistic effect of essential amino acids and glucose upon insulin secretion in man. Diabetes 1970, 19, 109–115. [Google Scholar]
  69. Anthony, J.C.; Lang, C.H.; Crozier, S.J.; Anthony, T.G.; MacLean, D.A.; Kimball, S.R.; Jefferson, L.S. Contribution of insulin to the translational control of protein synthesis in skeletal muscle by leucine. Am. J. Physiol. Endocrinol. Metab. 2002, 282, E1092–E1101. [Google Scholar]
  70. Nave, B.T.; Ouwens, M.; Withers, D.J.; Alessi, D.R.; Shepherd, P.R. Mammalian target of rapamycin is a direct target for protein kinase B: Identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J. 1999, 344, 427–431. [Google Scholar] [CrossRef]
  71. Lee, C.H.; Inoki, K.; Guan, K.L. mTOR pathway as a target in tissue hypertrophy. Annu. Rev. Pharmacol. Toxicol. 2007, 47, 443–467. [Google Scholar] [CrossRef]
  72. Crozier, S.J.; Kimball, S.R.; Emmert, S.W.; Anthony, J.C.; Jefferson, L.S. Oral leucine administration stimulates protein synthesis in rat skeletal muscle. J. Nutr. 2005, 135, 376–382. [Google Scholar]
  73. Greenhaff, P.L.; Karagounis, L.G.; Peirce, N.; Simpson, E.J.; Hazell, M.; Layfield, R.; Wackerhage, H.; Smith, K.; Atherton, P.; Selby, A.; et al. Disassociation between the effects of amino acids and insulin on signaling, ubiquitin ligases, and protein turnover in human muscle. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E595–E604. [Google Scholar] [CrossRef]
  74. Gulati, P.; Gaspers, L.D.; Dann, S.G.; Joaquin, M.; Nobukuni, T.; Natt, F.; Kozma, S.C.; Thomas, A.P.; Thomas, G. Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34. Cell Metab. 2008, 7, 456–465. [Google Scholar] [CrossRef]
  75. Juhasz, G.; Hill, J.H.; Yan, Y.; Sass, M.; Baehrecke, E.H.; Backer, J.M.; Neufeld, T.P. The class III PI(3)K Vps34 promotes autophagy and endocytosis but not tor signaling in Drosophila. J. Cell Biol. 2008, 181, 655–666. [Google Scholar] [CrossRef] [Green Version]
  76. Drummond, M.J.; Miyazaki, M.; Dreyer, H.C.; Pennings, B.; Dhanani, S.; Volpi, E.; Esser, K.A.; Rasmussen, B.B. Expression of growth-related genes in young and older human skeletal muscle following an acute stimulation of protein synthesis. J. Appl. Physiol. 2009, 106, 1403–1411. [Google Scholar] [CrossRef]
  77. Schalm, S.S.; Fingar, D.C.; Sabatini, D.M.; Blenis, J. TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function. Curr. Biol. 2003, 13, 797–806. [Google Scholar] [CrossRef]
  78. Han, J.M.; Jeong, S.J.; Park, M.C.; Kim, G.; Kwon, N.H.; Kim, H.K.; Ha, S.H.; Ryu, S.H.; Kim, S. Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 2012, 149, 410–424. [Google Scholar] [CrossRef]
  79. Nishimura, M.; Naito, S. Tissue-specific mRNA expression profiles of human solute carrier transporter superfamilies. Drug Metab. Pharmacokinet. 2008, 23, 22–44. [Google Scholar] [CrossRef]
  80. Palacin, M.; Estevez, R.; Bertran, J.; Zorzano, A. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol. Rev. 1998, 78, 969–1054. [Google Scholar]
  81. Baird, F.E.; Bett, K.J.; MacLean, C.; Tee, A.R.; Hundal, H.S.; Taylor, P.M. Tertiary active transport of amino acids reconstituted by coexpression of system A and L transporters in Xenopus oocytes. Am. J. Physiol. Endocrinol. Metab. 2009, 297, E822–E829. [Google Scholar] [CrossRef]
  82. Liu, X.M.; Reyna, S.V.; Ensenat, D.; Peyton, K.J.; Wang, H.; Schafer, A.I.; Durante, W. Platelet-derived growth factor stimulates LAT1 gene expression in vascular smooth muscle: Role in cell growth. FASEB J. 2004, 18, 768–770. [Google Scholar]
  83. Peyrollier, K.; Hajduch, E.; Blair, A.S.; Hyde, R.; Hundal, H.S. L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: Evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport. Biochem. J. 2000, 350, 361–368. [Google Scholar] [CrossRef]
  84. Philp, A.; Hamilton, D.L.; Baar, K. Signals mediating skeletal muscle remodeling by resistance exercise: PI3-kinase independent activation of mTORC1. J. Appl. Physiol. 2011, 110, 561–568. [Google Scholar] [CrossRef]
  85. Biolo, G.; Maggi, S.P.; Williams, B.D.; Tipton, K.D.; Wolfe, R.R. Increased rates of muscle protein turnover and amino acid transport after resistance exercise in humans. Am. J. Physiol. 1995, 268, E514–E520. [Google Scholar]
  86. Evans, W.J. Skeletal muscle loss: Cachexia, sarcopenia, and inactivity. Am. J. Clin. Nutr. 2010, 91, 1123–1127. [Google Scholar] [CrossRef]
  87. Morley, J.E.; Thomas, D.R.; Wilson, M.M. Cachexia: Pathophysiology and clinical relevance. Am. J. Clin. Nutr. 2006, 83, 735–743. [Google Scholar]
  88. Boirie, Y. Physiopathological mechanism of Sarcopenia. J. Nutr. Health Aging 2009, 13, 717–723. [Google Scholar] [CrossRef]
  89. Goodpaster, B.H.; Park, S.W.; Harris, T.B.; Kritchevsky, S.B.; Nevitt, M.; Schwartz, A.V.; Simonsick, E.M.; Tylavsky, F.A.; Visser, M.; Newman, A.B. The loss of skeletal muscle strength, mass, and quality in older adults: The health, aging and body composition study. J. Gerontol. A Biol. Sci. Med. Sci. 2006, 61, 1059–1064. [Google Scholar] [CrossRef]
  90. Park, S.W.; Goodpaster, B.H.; Strotmeyer, E.S.; de Rekeneire, N.; Harris, T.B.; Schwartz, A.V.; Tylavsky, F.A.; Newman, A.B. Decreased muscle strength and quality in older adults with type 2 diabetes: The health, aging, and body composition study. Diabetes 2006, 55, 1813–1818. [Google Scholar] [CrossRef]
  91. Newman, A.B.; Kupelian, V.; Visser, M.; Simonsick, E.M.; Goodpaster, B.H.; Kritchevsky, S.B.; Tylavsky, F.A.; Rubin, S.M.; Harris, T.B. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J. Gerontol. A Biol. Sci. Med. Sci. 2006, 61, 72–77. [Google Scholar] [CrossRef]
  92. Paddon-Jones, D.; Sheffield-Moore, M.; Katsanos, C.S.; Zhang, X.J.; Wolfe, R.R. Differential stimulation of muscle protein synthesis in elderly humans following isocaloric ingestion of amino acids or whey protein. Exp. Gerontol. 2006, 41, 215–219. [Google Scholar] [CrossRef]
  93. Paddon-Jones, D.; Sheffield-Moore, M.; Zhang, X.J.; Volpi, E.; Wolf, S.E.; Aarsland, A.; Ferrando, A.A.; Wolfe, R.R. Amino acid ingestion improves muscle protein synthesis in the young and elderly. Am. J. Physiol. Endocrinol. Metab. 2004, 286, E321–E328. [Google Scholar]
  94. Breen, L.; Phillips, S.M. Skeletal muscle protein metabolism in the elderly: Interventions to counteract the “anabolic resistance” of ageing. Nutr. Metab. (Lond.) 2011, 8, 68. [Google Scholar] [CrossRef]
  95. Yang, Y.; Breen, L.; Burd, N.A.; Hector, A.J.; Churchward-Venne, T.A.; Josse, A.R.; Tarnopolsky, M.A.; Phillips, S.M. Resistance exercise enhances myofibrillar protein synthesis with graded intakes of whey protein in older men. Br. J. Nutr. 2012. [Google Scholar] [CrossRef]
  96. Drummond, M.J.; Dreyer, H.C.; Pennings, B.; Fry, C.S.; Dhanani, S.; Dillon, E.L.; Sheffield-Moore, M.; Volpi, E.; Rasmussen, B.B. Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging. J. Appl. Physiol 2008, 104, 1452–1461. [Google Scholar] [CrossRef]
  97. Kumar, V.; Selby, A.; Rankin, D.; Patel, R.; Atherton, P.; Hildebrandt, W.; Williams, J.; Smith, K.; Seynnes, O.; Hiscock, N.; et al. Age-related differences in the dose-response relationship of muscle protein synthesis to resistance exercise in young and old men. J. Physiol. 2009, 587, 211–217. [Google Scholar]
  98. Durham, W.J.; Casperson, S.L.; Dillon, E.L.; Keske, M.A.; Paddon-Jones, D.; Sanford, A.P.; Hickner, R.C.; Grady, J.J.; Sheffield-Moore, M. Age-related anabolic resistance after endurance-type exercise in healthy humans. FASEB J. 2010, 24, 4117–4127. [Google Scholar] [CrossRef]
  99. Fry, C.S.; Glynn, E.L.; Drummond, M.J.; Timmerman, K.L.; Fujita, S.; Abe, T.; Dhanani, S.; Volpi, E.; Rasmussen, B.B. Blood flow restriction exercise stimulates mTORC1 signaling and muscle protein synthesis in older men. J. Appl. Physiol. 2010, 108, 1199–1209. [Google Scholar] [CrossRef]
  100. Symons, T.B.; Sheffield-Moore, M.; Mamerow, M.M.; Wolfe, R.R.; Paddon-Jones, D. The anabolic response to resistance exercise and a protein-rich meal is not diminished by age. J. Nutr. Health Aging 2011, 15, 376–381. [Google Scholar] [CrossRef]

Share and Cite

MDPI and ACS Style

Pasiakos, S.M. Exercise and Amino Acid Anabolic Cell Signaling and the Regulation of Skeletal Muscle Mass. Nutrients 2012, 4, 740-758. https://doi.org/10.3390/nu4070740

AMA Style

Pasiakos SM. Exercise and Amino Acid Anabolic Cell Signaling and the Regulation of Skeletal Muscle Mass. Nutrients. 2012; 4(7):740-758. https://doi.org/10.3390/nu4070740

Chicago/Turabian Style

Pasiakos, Stefan M. 2012. "Exercise and Amino Acid Anabolic Cell Signaling and the Regulation of Skeletal Muscle Mass" Nutrients 4, no. 7: 740-758. https://doi.org/10.3390/nu4070740

Article Metrics

Back to TopTop